AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Dibaglim M 1mg/850mg Tablet

Prescription Icon
Prescription Required

Marketer

Kasdap Healthcare Pvt Ltd

Salt Composition

Glimepiride (1mg) + Metformin (850mg)

Overview Dibaglim M 1mg/850mg Tablet

Glyciphage M 1mg/850mg tablets are classified as antidiabetic medications. This dual-action formulation treats type 2 diabetes in adults by regulating blood glucose. Administer this medication with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continue taking this medicine as prescribed, even with controlled blood sugar, as abrupt cessation can lead to elevated glucose, potentially causing kidney complications, vision impairment, neuropathy, and limb loss. This medication is one element of a comprehensive diabetes management plan including diet, exercise, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is a common side effect. Learn to recognize symptoms like sweating, dizziness, headache, and tremors, and know how to manage them promptly. Maintain regular mealtimes and carry a readily available fast-acting glucose source, such as sweets or juice. Alcohol consumption increases hypoglycemia risk and should be limited. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain is also possible. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Individuals with a history of heart disease should inform their physician before commencing treatment. Pregnant or lactating women require medical consultation prior to use. Regular blood glucose monitoring is essential, and your doctor may order blood tests to assess blood cell counts and liver function.

Uses of Dibaglim M 1mg/850mg Tablet

Managing type 2 diabetes

Major Benefits of Dibaglim M 1mg/850mg Tablet:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It's recommended to take Dibaglim M 1mg/850mg with a meal.

Common Side effects of Dibaglim M 1mg/850mg Tablet:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Dibaglim M 1mg/850mg Tablet:

Consume this medication precisely as your physician directs, adhering to the prescribed dosage and treatment period. Ingest the entire tablet; avoid chewing, crushing, or fracturing it. The Dibaglim M 1mg/850mg tablet should be administered with food.

How Dibaglim M 1mg/850mg Tablet works:

Each Dibaglim M 1mg/850mg tablet unites glimepiride (1mg) and metformin (850mg), two distinct antidiabetic agents. Glimepiride, a sulfonylurea, stimulates pancreatic insulin release, thus reducing blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose uptake, and enhancing insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol alongside Dibaglim M 1mg/850mg tablets poses a safety risk.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Dibaglim M 1mg/850mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against any possible risks prior to prescribing this medication. Seek medical advice before use.

Breast feedingBreast feedingUNSAFE

Lactation and Dibaglim M 1mg/850mg tablets are incompatible. Evidence indicates potential infant harm from this medication.

DrivingDrivingCAUTION

Driving may be impaired by excessively low or high blood glucose levels. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Patients with kidney impairment should use Dibaglim M 1mg/850mg tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates its use. Regular kidney function monitoring is recommended during treatment. Physician consultation is advised.

LiverLiverCAUTION

Patients with liver impairment should use Dibaglim M 1mg/850mg tablets cautiously, as dose modification may be necessary. Individuals with severe hepatic dysfunction should avoid this medication. A reduced initial dosage is typically prescribed for those with mild to moderate liver disease. Physician consultation is advised.

What if you forget to take Dibaglim M 1mg/850mg Tablet :

Should you forget to take your Dibaglim M 1mg/850mg Tablet, administer it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosage regimen. Avoid taking a double dose.

Facts to Know About Dibaglim M 1mg/850mg Tablet

LabelValue
Developing Habits No.
Type of Therapy Diabetes Management

FAQs on Dibaglim M 1mg/850mg Tablet

Store this medication in its original, tightly closed container, as directed on the label or packaging. Discard any unused medication and keep it out of reach of children, pets, and others.
Dibaglim M 1mg/850mg Tablets can cause lactic acidosis, a serious medical emergency resulting from excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare but potentially harmful side effect is more likely in patients with kidney disease, the elderly, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these symptoms, discontinue use and seek immediate medical attention.
Dibaglim M 1mg/850mg tablets combine glimepiride and metformin to manage type 2 diabetes mellitus (DM) in adults. This combination improves blood glucose control when used with a healthy diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. This medication is unsuitable for type 1 DM.
Dibaglim M 1mg/850mg tablets may cause common side effects such as low blood sugar (hypoglycemia), taste changes, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Prolonged use of Dibaglim M 1mg/850mg tablets can lead to vitamin B12 deficiency by hindering its absorption. This deficiency may cause anemia, neurological issues such as numbness, tingling in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate these risks, annual supplemental vitamin B12 is recommended by some researchers.
Dibaglim M 1mg/850mg Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Dibaglim M 1mg/850mg Tablet with alcohol is unsafe. This combination can cause dangerously low blood sugar (hypoglycemia) and increase the risk of lactic acidosis.
Dibaglim M 1mg/850mg Tabl...
74
MRP 90
17% off